Malignancy and rheumatoid arthritis

被引：32

作者：

Askling J. ^{[1
]}

机构：

[1] Clinical Epidemiology Unit M9:01, Department of Medicine Solna, Karolinska University Hospital Solna

来源：

Current Rheumatology Reports | 2007年 / 9卷 / 5期

关键词：

Rheumatoid Arthritis; Cancer Risk; Abatacept; Cancer Occurrence; Rheumatoid Arthritis Treatment;

D O I：

10.1007/s11926-007-0067-1

中图分类号：

学科分类号：

摘要：

The occurrence of cancer is not an infrequent event in patients with rheumatoid arthritis (RA). Indeed, following diagnosis of RA at a typical age (55 years), one in five patients will be diagnosed with cancer. In the vast majority of such cases, the cancer has nothing to do with RA or its treatment; rather, it represents the "background" risk applicable to all humans. In some cases, the cancer occurs as a result of factors also associated with the risk of developing RA (eg, smoking), even though no direct link exists between the cancer and the RA. In a fraction of cases, however, the cancer is causally associated with the RA disease or its treatments. This review summarizes our current understanding of the occurrence of cancer in RA, possible links to RA disease and to traditional and newer RA treatments. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：421 / 426

页数：5

共 45 条

[1] Cancer Incidence in Sweden 2005, (2007)
[2] Ekstrom K., Hjalgrim H., Brandt L., Et al., Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives, Arthritis Rheum, 48, pp. 963-970, (2003)
[3] Askling J., Fored C.M., Brandt L., Et al., Risks of solid cancers in patients with rheumatoid arthritis and following treatment with tumor necrosis factor antagonists, Ann Rheum Dis, 64, pp. 1421-1426, (2005)
[4] Wolfe F., Michaud K., The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation, Arthritis Rheum, 56, pp. 1433-1439, (2007)
[5] Franklin J., Lunt M., Bunn D., Et al., Influence of inflammatory polyarthritis on cancer incidence and survival: Results from a community-based prospective study, Arthritis Rheum, 56, pp. 790-798, (2007)
[6] Mellemkjaer L., Alexander F., Olsen J.H., Cancer among children of parents with autoimmune diseases, Br J Cancer, 82, pp. 1353-1357, (2000)
[7] Thomas E., Brewster D.H., Black R.J., Macfarlane G.J., Risk of malignancy among patients with rheumatic conditions, Int J Cancer, 88, pp. 497-502, (2000)
[8] Tennis P., Andrews E., Bombardier C., Et al., Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada, J Clin Epidemiol, 46, pp. 685-695, (1993)
[9] Franklin J., Lunt M., Bunn D., Et al., Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis, Ann Rheum Dis, 65, pp. 617-622, (2006)
[10] Smedby K.E., Hjalgrim H., Askling J., Et al., Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype, J Natl Cancer Inst, 98, pp. 51-60, (2006)

← 1 2 3 4 5 →